- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04262986
A Brief Lifestyle Modification Programme in Overweight Subjects With Obstructive Sleep Apnoea - Needs Assessment
A Brief Motivational Enhancement Lifestyle Modification Programme to Reduce Body Weight in Overweight Subjects With OSA: Needs Assessment
Obstructive sleep apnea (OSA) is a common chronic disease and associated with cardiovascular and neurocognitive sequelae. Overweight is a common, reversible risk factor of OSA, and the rapid rise in obesity worldwide may lead to increases in OSA and related adverse health outcomes. Weight-loss interventions, especially comprehensive lifestyle interventions, are associated with improvements in OSA severity, cardiometabolic comorbidities, and quality of life. However, the intensive nature of these programmes often pose a barrier to adherence. Furthermore, although there is strong evidence to support the value of mobile text messaging to promote physical activity and healthy eating in clinical and community settings, messaging has rarely been applied in interventions for overweight OSA subjects.
The proposed study aims to examine the feasibility of a brief lifestyle modification programme that makes use of smartphone technology (WhatsApp or WeChat) to empower subjects to start doing simple and easy-to-do exercises that can be easily integrated into daily life for gradual lifestyle change.
Visão geral do estudo
Status
Condições
Descrição detalhada
Obstructive sleep apnea (OSA) is a common chronic disease and associated with cardiovascular and neurocognitive sequelae. Overweight is a common, reversible risk factor of OSA, and the rapid rise in obesity worldwide may lead to increases in OSA and related adverse health outcomes. Weight-loss interventions, especially comprehensive lifestyle interventions, are associated with improvements in OSA severity, cardiometabolic comorbidities, and quality of life. However, non-adherence is commonly seen in such lifestyle modification programmes. Such programmes are often intensive and pose a barrier to adherence. Researchers have suggested that programmes with fewer sessions may improve the completion rates. As yet, there have been no randomised trial assessing the feasibility and effectiveness of a brief theory-based lifestyle modification programme.
Furthermore, although there is strong evidence to support the value of mobile text messaging to promote physical activity and healthy eating in clinical and community settings, messaging has rarely been applied in interventions for overweight OSA subjects. In Hong Kong, where smartphone penetration is extensive (89% in 2017), utilising messaging as an intervention tool may be especially valuable.
The proposed study will examine the perceived burden and informational needs and preferences of overweight subjects with OSA, especially in relation to physical activity. The study will also examine the feasibility of a brief lifestyle modification programme that makes use of smartphone technology (WhatsApp or WeChat) to provide personalised support and empower subjects to start doing simple and easy-to-do exercises that can be easily integrated into daily life for gradual lifestyle change and weight reduction.
Tipo de estudo
Inscrição (Antecipado)
Contactos e Locais
Contato de estudo
- Nome: Agnes YK Lai, PhD
- Número de telefone: (+852)3917-6328
- E-mail: agneslai@hku.hk
Estude backup de contato
- Nome: Mary Ip, MD
- Número de telefone: (+852)2255-4455
- E-mail: msmip@hku.hk
Locais de estudo
-
-
-
Hong Kong, Hong Kong
- Recrutamento
- The University of Hong Kong
-
Investigador principal:
- Agnes YK Lai, PhD
-
Contato:
- Agnes YK Lai, PhD
- Número de telefone: (+852)3917-6328
- E-mail: agneslai@hku.hk
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Aged 18 years or above;
- Performed sleep test in sleep laboratory; and
- Mentally fit to provide informed consent and answer self-administered questionnaire.
Exclusion Criteria:
- Those on CPAP or oral appliance treatment;
- Diagnosed with psychiatric illness; or
- Unwilling to give informed consent.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Preference on physical activity
Prazo: Immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
Immediately after obtaining written consent
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Current physical activity practices
Prazo: Immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
Immediately after obtaining written consent
|
|
Preference on programme contents and information
Prazo: Immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
Immediately after obtaining written consent
|
|
Preference on m-Health information
Prazo: Immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
Immediately after obtaining written consent
|
|
Daytime Sleepiness
Prazo: Immediately after obtaining written consent
|
Epworth Sleepiness Scale, ranged from 0 - 24 scores.
The ESS score (the sum of 8 item scores, 0-3) can range from 0 to 24.
The higher the ESS score, the higher that person's average sleep propensity in daily life.
Score >10 is interpreted as excessive daytime sleepiness
|
Immediately after obtaining written consent
|
|
Sleep quality
Prazo: Immediately after obtaining written consent
|
A single-item sleep quality scale; range from 0 -10; Higher score is interpreted as better sleep quality
|
Immediately after obtaining written consent
|
|
Dietary consumption habits
Prazo: Immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
Immediately after obtaining written consent
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Agnes YK Lai, PhD, School of Nursing, The University of Hong Kong
Publicações e links úteis
Publicações Gerais
- Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health. 2015 Mar 18;36:393-415. doi: 10.1146/annurev-publhealth-031914-122855.
- Dobrosielski DA, Papandreou C, Patil SP, Salas-Salvado J. Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk. Eur Respir Rev. 2017 Jun 28;26(144):160110. doi: 10.1183/16000617.0110-2016. Print 2017 Jun 30.
- Hudgel DW, Patel SR, Ahasic AM, Bartlett SJ, Bessesen DH, Coaker MA, Fiander PM, Grunstein RR, Gurubhagavatula I, Kapur VK, Lettieri CJ, Naughton MT, Owens RL, Pepin JL, Tuomilehto H, Wilson KC; American Thoracic Society Assembly on Sleep and Respiratory Neurobiology. The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Sep 15;198(6):e70-e87. doi: 10.1164/rccm.201807-1326ST.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- UW 20-068-1
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .